Health
South Korea’s trainee doctors defy pressure to end strike
Thousands of South Korean trainee doctors are refusing to return to work on Thursday, the government’s deadline for ending a massive strike, warning that the
US FDA to step up inspections of drug manufacturing facilities in India
The US drug regulator is set to increase inspections at Indian drug manufacturing facilities in 2024 amid growing concerns over drug quality, a top Food
Eli Lilly may launch an obesity drug in India next year
U.S. drugmaker Eli Lilly plans to launch Mounjaro, its blockbuster diabetes treatment and hugely popular obesity drug, in India as early as next year, CEO
South Korea to send military doctors to hospitals
South Korea will send its military and community doctors to hospitals in the coming days following a massive strike by junior doctors, Prime Minister Han
Takeda partners with Biological E. to boost dengue vaccine production
Japan’s Takeda Pharmaceutical will increase production of its dengue vaccine Qdenga through a partnership with Indian vaccine maker Biological E., the two companies announced.
New Zealand set to repeal the world’s first tobacco ban
New Zealand will on Tuesday repeal the world’s first law banning the sale of tobacco to future generations, the government said, despite researchers and campaigners
UK-based Smith+Nephew sees profitability rise amid strong demand
British medical device maker Smith+Nephew on Tuesday forecast improved profitability this year after broadly meeting market expectations for earnings in 2023, driven by strong growth
GSK’s gonorrhoea drug hits major target in late-stage trial
British drugmaker GSK said its oral drug to treat gonorrhoea has achieved a key goal of staying ahead of existing combination drugs in late-stage trials.
Roche’s Xolar reduces severe food allergy reactions in study
Xolar, an asthma drug marketed 20 years ago by Roche and Novartis significantly reduced allergic reactions in people with multiple severe food allergies in a
South Korea gives doctors until the end of February to return to work
South Korea’s government told junior doctors on Monday they had until the end of February to return to work or risk being punished for staging